Healthcare resource utilization and costs in individuals with Huntington's disease by disease stage in a US population.

HRU and costs of care are high among individuals with HD, particularly among those with middle- and late-stage disease. This indicates that the disease burden in HD increases with disease stage, highlighting the need for interventions that can slow or prevent disease progression.